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Abstract
Prostate cancer (PCa) is a leading cause of death among males. It is currently estimated that inflammatory
responses are linked to 15-20% of all deaths from cancer worldwide. PCa is dominated by complications arising from
metastasis to the bone where the tumor cells interact with the bone microenvironment impairing the balance between
bone formation and degradation. However, the molecular nature of this interaction is not completely understood.
Heme oxygenase-1 (HO-1) counteracts oxidative damage and inflammation. Previous studies from our laboratory
showed that HO-1 is implicated in PCa, demonstrating that endogenous HO-1 inhibits bone derived-prostate cancer
cells proliferation, invasion and migration and decreases tumor growth and angiogenesis in vivo. The aim of this work
was to analyze the impact of HO-1 modulated PCa cells on osteoblasts proliferation in vitro and on bone remodeling
in vivo. Using a co-culture system of PC3 cells with primary mice osteoblasts (PMOs), we demonstrated that HO-1
pharmacological induction (hemin treatment) abrogated the diminution of PMOs proliferation induced by PCa cells
and decreased the expression of osteoclast-modulating factors in osteoblasts. No changes were detected in the
expression of genes involved in osteoblasts differentiation. However, co-culture of hemin pre-treated PC3 cells (PC3
Hem) with PMOs provoked an oxidative status and activated FoxO signaling in osteoblasts. The percentage of active
osteoblasts positive for HO-1 increased in calvarias explants co-cultured with PC3 Hem cells. Nuclear HO-1
expression was detected in tumors generated by in vivo bone injection of HO-1 stable transfected PC3 (PC3HO-1)
cells in the femur of SCID mice. These results suggest that HO-1 has the potential to modify the bone
microenvironment impacting on PCa bone metastasis.
Citation: Ferrando M, Wan X, Meiss R, Yang J, De Siervi A, et al. (2013) Heme Oxygenase-1 (HO-1) Expression in Prostate Cancer Cells Modulates the
Oxidative Response in Bone Cells. PLoS ONE 8(11): e80315. doi:10.1371/journal.pone.0080315
Editor: Zoran Culig, Innsbruck Medical University, Austria
Received August 29, 2013; Accepted October 6, 2013; Published November 4, 2013
Copyright: © 2013 Ferrando et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by grants from the University of Buenos Aires, Argentina, UBACyT (20020100100179) and ANPCYT (PICT RAICES
2010-0431). M. F. held fellowships from CONICET and UICC International Cancer Technology Transfer Fellowship. The funders had no role in study
design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
* E-mail: elba@qb.fcen.uba.ar
Introduction
Bone metastases dominate the clinical picture of advanced
prostate cancer (PCa) and are responsible for most of the
mortality and morbidity of the disease. Metastases to bone may
have either an osteolytic (bone resorbing) or an osteoblastic
(bone producing) phenotype. PCa characteristically produces
osteoblastic lesions in bone, although an osteolytic component
is always present.
It has been suggested that inflammation increases prostate
tumorigenesis [1]. Cytokines, chemokines and matrix
metalloproteinases are part of a proinflammatory network that
contributes to malignant progression [2]. Indeed,
proinflammatory factors secreted by PCa and bone cells and
the subsequent released of factors from the organic matrix in
the bone, mediate a paracrine/autocrine interaction between
PCa cells, osteoblasts and osteoclasts, which ultimately
determine the bone phenotype and progression of PCa [3,4].
Oxidative stress is a natural consequence of inflammatory
processes and acts as a modulator of the function of
mineralized tissues [5]. It affects bone formation by inhibiting
the differentiation of osteoblasts and promoting apoptosis [6].
These effects are mediated in part by reactive oxygen species
(ROS) generated in the context of oxidative stress. Cells
counteract the adverse effects of ROS by activating various
defense mechanisms, including induction of free radical
scavenging enzymes such as manganese superoxide
dismutase (MnSOD), catalase, and also DNA repair genes.
This response requires the activation of a family of ubiquitous
factors known as forkhead transcription box O (FoxO) [7],
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which through interaction with β-catenin reduces oxidative
stress and promotes osteoblasts survival [6].
Heme oxygenase 1 (HO-1), the rate-limiting enzyme in heme
degradation, was demonstrated to confer cytoprotection
against oxidative stress and inflammation in several animal
models [8]. Previous reports from our laboratory documented
for the first time the nuclear expression of HO-1 in human
primary prostate carcinomas [9]. We also documented that
HO-1 inhibits cell proliferation, migration, and invasion in vitro
and impairs PCa tumor growth in vivo [10]. In addition, we
previously established a key role for HO-1 as a modulator of
the angiogenic switch in prostate carcinogenesis [11].
Moreover, we showed evidence that the anti-angiogenic
function of HO-1 was mediated by repression of the nuclear
factor kappa-light-chain-enhancer of activated B cells (NF-κB)
signaling pathway [11]. Recently, we reported a novel function
for HO-1 in PCa. We demonstrated that HO-1 down-modulates
AR transcriptional activity by interfering with STAT3 signaling
and provided evidence of its role beyond heme degradation
[12].
The studies presented here were performed using a bone
derived osteolytic PCa cell line (PC3) that has been shown to
inhibit osteoblast proliferation in vitro in a co-culture system
with primary mouse osteoblasts (PMOs) [13]. In this paper we
report data that support a novel function for HO-1 in the
interaction between PCa cells and bone. We found that HO-1
induction in PC3 cells restored the proliferation of osteoblasts,
which was inhibited during co-culture with parental PC3 cells.
Our studies suggest that these effects are mediated by the
activation of FoxO signaling in osteoblasts. PC3 cells
overexpressing HO-1 (PC3HO-1) growing in the bone of mice,
produced tumors with nuclear localization of HO-1 as detected
by immunohistochemistry. These data indicate that HO-1 plays
a role in the progression of PCa in bone. A better
understanding of the molecular mechanisms underlying the
interplay between PCa cells and bone microenvironment may
help to identify novel targets for pharmacological intervention in
this disease.
Materials and Methods
Cell Cultures and Antibodies
The prostate cancer cell line PC3 was obtained from the
American Type Culture Collection (Manassas, VA, USA) and
routinely cultured in RPMI 1640 (Invitrogen, CA, USA)
supplemented with 10% fetal bovine serum (FBS). PC3 stable
transfected cells (PC3HO-1 and PC3βgal) were generated as
described previously [10]. The mouse myoblast cell line C2C12
was obtained from the American Type Culture Collection
(Manassas, VA, USA) and was cultured in DMEM low-glucose
(Invitrogen, CA, USA) with 10% FBS. Primary cultures of mice
osteoblasts (PMOs) were established by a procedure published
previously [13] and were obtained from the calvaria of newborn
CD1 mice sacrificed 4 days after birth. Isolated cells were
plated in α-MEM (Invitrogen, CA, USA) plus 10% FBS for 48 h.
The PMOs were then subsequently trypsinized and replated in
culture dishes to perform experiments. Antibodies: anti–HO-1
was from Stressgen Biotechnologies, Corp. (San Diego, CA,
USA), anti-β-Catenin was from BD Transduction
Laboratories™ (CA, USA), anti–β-actin was from Cell Signaling
Technology (Beverly, MA, USA), anti-cyclin B1, anti-cyclin A,
anti-cyclin D1, anti-p21, anti-β-tubulin, anti-mouse and anti-
rabbit secondary antibodies were from Santa Cruz
Biotechnology Inc. (CA, USA) and Alexa Fluor® 594-
conjugated secondary antibody from Invitrogen (CA, USA).
Hemin pre-treatment of PCa cells and co-culture
system
An in vitro bicompartment culture system was used as a
model of bone metastases from PCa as previously described
slightly modified [13]. In brief, on day 0 PC3 cells were seeded
(10,500 cell/cm2) in cell-culture inserts (0.4-mm pore; Falcon/
Becton Dickinson Labware, Franklin Lakes, NJ, USA) and on
day 1 they were treated with hemin (80 μM, Sigma-Aldrich, St
Louis, MO, USA), a potent inducer of HO-1 (PC3 Hem).
Controls received fresh medium. The PMOs were also seeded
on day 1 in tissue culture plates (7,300 cell/cm2). On day 2, the
inserts containing the PC3 cells (pre-treated or not with hemin)
were extensively washed with PBS. Then, the inserts were
placed into tissue-culture plates containing the PMOs so that
the two different cell types shared the culture medium but were
not in physical contact. Co-culturing of PC3 cells with PMOs
was performed with α-MEM plus 2% FBS for 24 h. On day 3,
the cells were collected and different parameters were
analyzed. As control, each cell type (PC3 cells pre-treated or
not with hemin and PMOs) was grown alone. Co-cultures of
C2C12 cells and PC3 were done in the same conditions like
PMOs and PC3 cells. Cultures were done in triplicate and each
experiment was assayed three times.
Mitogenic assay
Proliferation and DNA synthesis were assessed by adding
[3H]-thymidine (Amershan Biosciencies) during the final 3 h of
co-culture and incorporation was measured as described
elsewhere [14].
RNA isolation and RT-qPCR (reverse transcription
quantitative PCR)
Total RNA was isolated with the RNeasy Mini Kit (Qiagen).
cDNAs were synthesized with RevertAid RT (Fermentas) and
amplified by real-time PCR amplification with Taq DNA
Polimerase (Fermentas). Primers were designed using Beacon
Designer 5 and tested with UCSC Genome Browser Home
URL. The PCR was performed in a DNA Engine Opticon (MJ
Research). Human primer sequences were given as follows:
ACTB 5´-AAGATCATTGCTCCTCCTGAGC-3´ and 5´-
CATACTCCTGCTTGCTGATCCA-3´; HO-1 5´-
GAGTGTAAGGACCCATCGGA-3´ and 5´-
GCCAGCAACAAAGTGCAAG-3´; PTHrP 5´-
GTCTCAGCCGCCGCCTCAA-3´ and 5´-
GGAAGAATCGTCGCCGTAAA-3´; uPA 5´-
GAGATCACTGGCTTTGGAAAA-3´ and 5´-
CCAGCTCACAATTCCAGTCA-3´; TGF-β1 5´-
TACCTGAACCCGTGTTGCTC-3´ and 5´-
GCGAAAGCCCTCAATTTCCC-3´. Mouse primer sequences
were given as follows: ACTB 5´-
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CCGCACGACAACCGCACCAT-3´ and 5´-
CGGTTGGCCTTAGGGTTCAGGGGGG-3´; Runx-2 5´-
CCGCACGACAACCGCACCAT-3´ and 5´-
AGGCATTTCGGAGCTCGGCG-3´; ALP 5´-
AACCCAGACACAAGCATTCC-3´ and 5´-
GAGACATTTTCCCGTTCACC-3´; Col1a1 5´-
CATGTTCAGCTTTGTGGACCT-3´ and 5´-
GCAGCTGACTTCAGGGATGT-3´; Col1a2 5´-
GCAGGTTCACCTACTCTGTCCT-3´ and 5´-
CTTGCCCCATTCATTTGTCT-3´; OCN 5´-
GCAGCTTGGTGCACACCTAG-3´ and 5´-
GGAGCTGCTGTGACATCCATAC-3´; RANKL 5´-
TGATTCATGTAGGAGAATTAAACAGG-3´ and 5´-
GATGTGCTGTGATCCAACGA-3´; OPG 5´-
GAAGGGCGCTACCTTGAGAT-3’ and 5´-
GCAAACTGTATTTCGCTCTGG-3´; CSF-1 5´-
CAACAGCTTTGCTAAGTGCTCTA-3´ and 5´-
CACTGCTAGGGGTGGCTTTA-3´; OPN 5´-
CTTTCACTCCAATCGTCCCTA-3´ and 5´-
GCTCTCTTTGGAATGCTCAAGT-3´; CCL2 5´-
TGCTACTCATTAACCAGCAAGAT-3´ and 5´-
TGCTTGAGGTGGTTGTGGAA-3´; IL-6 5´-
CTGCAAGAGACTTCCATCCAGTT-3´ and 5´-
GAAGTAGGGAAGGCCGTGG-3´; MnSOD 5´-
CCACACATTAACGCGCAGATC-3´ and 5´-TAACATCTCCCTT
GGCCAGAGC-3´; catalase 5´-
TTGCTGAAGTTGAACAGATGG-3´ and 5´-
ATCACGCTGGTAGTTGGC-3´.
Western blot analysis
For western blotting, 50 µg of protein was separated on 12%
Tris-glycine polyacrylamide gels and transferred to
nitrocellulose membranes (BIORAD POWERPAC Basic). The
specific proteins were detected by chemiluminescence
(Amersham) as previously described [10].
Plasmids, transfections and luciferase reporter assay
A TOP-flash reporter gene construct containing four
consensus TCF binding sites, a minimal Fos binding site and a
luciferase reporter was used [15]. A FOP-flash construct with a
mutated TCF binding site was used as a negative control. A
reporter plasmid containing 6 copies of daf-16 family protein
binding element (FoxO-luc) in the pGL3-basic firefly luciferase
vector with a minimal TATA box [16] was kindly provided by B.
Burgering, University Medical Center, Utrecht, Netherlands.
Luciferase reporter constructs were introduced into C2C12
cells by transient transfection using 8 µg of PEI and 4 µg of
plasmid. After 6 h, the medium was removed and the C2C12
were co-cultured with PC3 cells pre-treated or not with hemin
or grown alone for 24 h. C2C12 cells were then harvested and
lysed with 40 μl of Steady Glo Luciferase System (Promega,
Madison, WI, USA). Luciferase activity was measured in a
luminometer (Glomax Multi Detection System; Promega). As
positive control of TCF binding sites activation, PMOs were
treated with LiCl 10 mM for 24 h and of FoxO-luc activation,
cells were exposed to H2O2 100µM for 24 h. Each transfection
was done in triplicate and each experiment was repeated at
least three times. Data were normalized to total protein
determined by the Bradford assay.
Assessment of reactive oxygen species by flow
cytometry
After the co-culture, the PMOs were washed with PBS and
incubated with 10 µM 2´,7´- Dichlorofluorescein diacetate
(CM2-DCFHDA; Invitrogen-Molecular ProbesTM) for 1 h at
37°C. The cells were tripsined and resuspended with PBS. The
levels of H2DCFDA were measured by flow citometry in the
FITC channel.
Cell cycle
After the co-culture, PMOs were fixed and stained with
propidium iodide (PI), and analyzed by fluorescence-activated
cell sorting (FACS) as previously described [17].
Immunofluorescence
PMOs were co-cultured as described previously but seeded
on coverslips. The immunofluorescence analyses were
performed as previously described [12]. Wide field microscopy
was carried out using an Olympus IX71 microscope with a
water immersion objective (UPLSAPO 60XW 1,2 AN,
Olympus). Images were taken with the camera Hamammatsu
Orca-ER using the software Andor IQ and were processed for
presentation with ImageJ (http://rsb.info.nih.gov, National
Institutes of Health).
Immunohistochemical analyses
Immunohistochemical technique was performed as
previously described [9,10]. For quantitative analysis, the total
number of osteoblasts in at least 6 fields was counted and the
percentage of osteoblasts with positive immunoreactivity for the
studied gene was calculated.
Organ culture
Calvaria from 4-day-old CD1 mouse pups were excise, cut in
half and placed in BGJ medium (Sigma Aldrich) containing
0.1% bovine serum albumin on a cell culture insert that
suspends the bone organ between atmosphere and medium
for optimal CO2 exchange. Half of each calvaria was co-
cultured with PC3 cells pre-treated with hemin and the other
half with PC3 untreated cells. Other calvarias were placed in
BGJ medium containing 0.1% bovine serum albumin and used
as controls. Other halves treated with insulin 20 µg/ml were
used as positive controls of bone formation. The corresponding
PC3 culture and the medium were changed every 2 days and
the experiment was terminated at the end of 7 days. At that
time, the calvaria halves were fixed, decalcified, paraffin-
embedded, sectioned, stained with hematoxylin and eosin or
immunohistochemical stainned and analyzed as previously
described [13].
In vivo prostate cancer intrabone model
All animal experiments were conducted in accordance with
accepted standards of animal care and were approved by the
Institutional Animal Care and Use
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Committee of the University of Texas MD Anderson Cancer
Center. PC3HO-1 or PC3βgal cells were injected into the
femurs of male SCID mice (Charles River Laboratories,
Wilmington, MA, USA) as previously described [13]. 3 × 105
PCa cells per mouse were injected with a 28-gauge needle
into the distal ends of the right femurs of 6- to 8-week-old
intact male SCID mice (n=7 per group) according to
procedures described elsewhere. Bone formation was
assessed by X-ray analysis. At the end of the experiment,
mice were euthanized by cervical dislocation after anesthesia
with isoflurane, (delivered by the open-*drop method*) after
which their hind legs were removed and the muscle tissues
dissected from the bones of both the injected and control hind
limbs of mice bearing the femoral xenografts. The dissected
bones were then processed for histologic.
Statistical analysis
All results are given as mean ± SD of 3 separate
independent experiments unless stated otherwise. Student’s t
test was used to ascertain statistical significance with a
threshold of P<0.05 (*), P<0.01(**) and P<0.001 (***).
Results
HO-1 expression in PC3 cells impairs growth inhibitory
effects of tumor cells on osteoblasts proliferation
In vivo, PC3 cells predominantly produce bone-resorbing
effects leading to osteolytic bone lesions [18]. In vitro, it was
well documented that when PMOs were co-cultured with PC3
cells the number of PMOs decreased significantly [13]. In order
to analyze the effect of HO-1 on the interaction between PCa
cells and osteoblasts, HO-1 expression in PC3 cells was
induced by pre-treatment with hemin (PC3 Hem) (80 μM, 24 h).
PC3 Hem and control cells were then co-cultured with PMOs
during 24 h. We confirmed the inhibitory effect of PC3 cells on
osteoblasts proliferation as assessed by 3H-thymidine
incorporation and cell number (57% and 28%, P<0.05;
respectively) (Figure 1 A&B). Noticeably, the co-culture of
PMOs with PC3 Hem restored osteoblasts proliferation at
levels found in PMOs growing alone (Figure 1 A&B), further
emphasizing the pro-homeostatic role of HO-1. The induction
of HO-1 expression in PC3 cells was confirmed at mRNA and
protein levels (Figure 1).
The analyses of proteins involved in cell cycle regulation by
immunoblotting in PMOs after co-culture with PC3 Hem
showed an increase in the levels of cyclin A, cyclin B and cyclin
D1, with a concomitant decrease in p21WAF1/CIP1 expression as
compared to PMOs grown in co-culture with PC3 control cells
(Figure 1C). Furthermore, flow cytometric analysis of PMOs
after co-culture with PC3 Hem demonstrated significant
increased on G2/M accumulation as compared to PMOs co-
culture with PC3 control cells (P<0.05) (data not shown). All
these data suggest that HO-1 expression in PCa cells induces
cell cycle progression in PMOs, restoring the growth rate of
PMOs alone. It is worth to remark that the number of PC3 cells
was not modified in the different co-culture conditions assayed
(data not shown).
HO-1 expression in PC3 cells does not alter the effects
of tumor cells on osteoblasts differentiation
Transcript levels of various osteoblasts specific genes were
assessed by RT-qPCR. The expression of the osteoblasts
specific transcription factor Runx-2, of an early differentiation
marker (alkaline phosphatase, ALP), of late differentiation
markers involved in collagenous matrix deposition (collagen
type I and collagen type II) and non-collagenous matrix
deposition (osteocalcin, OCN) was analyzed. We found that
Runx-2 expression was increased in PMOs co-cultured with
PC3 Hem (130%, P<0.05) (Figure 2 A) but no differences were
detected in the levels of ALP, collagen type I and II in PMOs
growing alone or in co-culture with PC3 Hem or PC3 control
cells (Figure 2 B-D). OCN levels were significantly decreased
in PMOs co-cultured with PC3 Hem or PC3 controls (81% and
68%, P<0.01; respectively) (Figure 2 E). In agreement with
previous reports [13,19,20], PMOs co-cultured with PC3 cells
exhibited a decrease in calcified matrix formation as assessed
by von Kossa staining compared with PMOs growing alone
(Figure 2). No alteration was detected on calcified matrix when
PMOs were co-cultured with PC3 Hem (Figure 2). These
results demonstrate that PC3-secreted factors, reported to be
responsible of the inhibition of osteoblasts differentiation [13],
are not modified when HO-1 expression is induced in tumor
cells.
HO-1 expression in PC3 cells decreased the levels of
osteoclast-modulating factors in osteoblasts
Receptor activator of nuclear factor kappa-B ligand (RANKL)
and Osteoprotegerin (OPG) are produced by osteoblastic/
stromal cells. RANKL has been shown to activate mature
osteoclasts and mediate osteoclastogenesis. OPG acts as a
decoy receptor for RANKL [21]. The co-culture of PMOs and
PC3 Hem cells produced an increase in RANKL and a
decrease in OPG transcript levels in osteoblasts; the same
result was observed after co-culture of PMOs with PC3 control
cells (Figure 3 A&B).
Osteoblasts also produce cytokines and other growth factors
that promote osteoclasts development and activation, such as
colony stimulating factor-1 (Csf-1), osteopontin (OPN),
chemokine (C-C motif) ligand 2 (CCL2) and interleukin-6 (IL-6).
We found that PMOs co-cultured with PC3 Hem expressed
significant lower transcript levels of Csf-1, OPN and CCL2 as
compared to PMOs grown alone (52%, P<0.01; 53%, P<0.001
and 52%, P<0.05; respectively). No differences were detected
in IL-6 levels (Figure 3 C-F).
PCa cells also express genes indirectly involved in
osteoclasts modulation. Therefore, we decided to investigate
the expression in PC3 cells of parathyroid hormone-related
peptide (PTHrP), urokinase-type plasminogen activator (uPA)
and transforming growth factor beta 1 (TGF-β1) by RT-qPCR
and the activity of matrix metalloprotease 9 (MMP9) by
zymography. No differences were observed in the transcripts
levels of the selected genes or in the activity of MMP9 (Figure
4), indicating that these genes implicated in osteoclasts
modulation are not altered in PC3 cells under the experimental
conditions either pre-treated or not with hemin growing alone or
in co-culture.
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Onset of osteoblasts oxidative status by co-culture
with hemin pre-treated PC3 cells
Previous reports indicate that oxidative stress leads to
decreased osteoblasts number and bone formation rate [22]. In
order to investigate whether PCa cells induce oxidative stress
in osteoblasts, we used our co-culture system to analyze the
expression of antioxidant response genes (MnSOD, catalase
and HO-1). The co-culture of PMOs with PC3 Hem or PC3
controls increased the transcript levels of MnSOD (134% and
206%, P<0.05; respectively) and catalase (95% and 35%,
P<0.05; respectively) in PMOs (Figure 5 A&B). Interestingly,
HO-1 protein expression in osteoblasts co-cultured with PC3
Hem or PC3 controls was strongly induced compared to PMOs
growing alone (Figure 5 C). To determine the oxidative stress
levels, the generation of ROS was measured by flow cytometry
monitoring H2DCFDA oxidation. Significant increased levels of
ROS were found in PMOs co-cultured with PC3 Hem
compared to PMOs growing alone (15%, P<0.01) (Figure 5 D).
Together these findings suggest that induced HO-1 expression
in PC3 cells releases soluble factors leading to oxidative stress
in PMOs. This in turn induces an antioxidant response probably
favoring osteoblasts proliferation [6].
HO-1 expression in PC3 cells activates FoxO signaling
in C2C12 cells
In order to identify signaling pathways activated by oxidative
stress in osteoblasts, we analyzed β-catenin/Foxo axis.
Although canonical Wnt/β-catenin pathway plays a pivotal role
in regulating osteoblast differentiation and bone formation, it is
well known that soluble β-catenin interacts with FoxO
transcription factors in response to oxidative stress [6]. To
study this signaling pathway we used a reporter construct with
six FoxO response elements. Due to the difficulty to transfect
PMOs, we used an uncommitted mesenchymal cell line,
Figure 1.  Co-culture with HO-1-induced PC3 cells restored PMOs proliferation.  Experiments were done in PMOs grown alone
(PMO), co-cultured with PC3 (PMO PC3) or with PC3 pre-treated with hemin (PMO PC3 Hem). A: Cell proliferation was measured
by 3H-thymidine incorporation in PMOs after 24h culture. Results are expressed as a percentage of the PMOs monoculture set at
100%. B: PMOs cell number. C: Western blot analysis was carried out by using anti-cyclin B1, A, and D1 and anti–p21WAF1/CIP1
antibodies. The numbers under the bands indicates the quantitation normalized to β-Tubulin and PMOs alone. One representative
from at least three independent experiments is shown (Significant difference, * P<0.05; No significant difference, NS).
doi: 10.1371/journal.pone.0080315.g001
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C2C12, able to differentiate into the osteoblastic lineage [23].
The co-culture of C2C12 cells with PC3 Hem strongly
stimulated the activity of the reporter gene (Figure 6 A). As
positive control C2C12 cultures were exposed to H2O2 (100
μM) (Figure 6 A). The results outlined here suggest that soluble
factors produced by PC3 Hem induce FoxO signaling in
osteoblasts.
In the Wnt canonical pathway, β-catenin activation results in
stabilization of the protein translocation into the nucleus, where
it interacts with TCF (T-cell factor, HMG box) and activates
transcription of target genes [24]. It has been suggested that
Foxo divert β-catenin from the Wnt canonical pathway [6]. To
assess whether Wnt canonical pathway in PMOs is altered
after co-culture with PCa cells, we examined β-catenin
subcellular localization and TCF activation in PMOs growing
alone or in co-culture with PC3 Hem and PC3 control cells. The
images showed in Figure 6 C demonstrate that β-catenin is
located both in the nucleus and in the cytoplasm in all the
analyzed conditions. To evaluate the activation of the β-
catenin/TCF pathway we used a reporter gene. We co-cultured
PC3 cells pre-treated or not with hemin with C2C12 cells that
had been transfected with a TCF reporter gene construct
(TOP-flash) [15]. C2C12 cells treated with LiCl (20 mM) were
used as a positive control and FOP-flash reporter activity as a
negative control. No differences in TCF reporter activity were
detected when C2C12 cells were grown alone or co-cultured
with PC3 Hem or PC3 control cells (Figure 6 B).
Bone explant co-culturing with PC3 cells induces HO-1
expression
To extend these results, we used a bone organ culture
assay. PC3 Hem or PC3 control cells were co-cultured with
mouse calvaria explants. The histological analysis showed no
differences in bone formation when calvarias were grown alone
(control) or in co-culture (Figure 7 A-C). Using the
immunohistochemistry technique we next explored the
expression of HO-1. As shown in Figure 7 (E-H) the
percentage of active osteoblasts with HO-1 positive reactivity
was higher in the calvarias co-cultured with the tumor cells than
in controls. This increase was even higher when the calvarias
were co-cultured with PC3 Hem cells (Figure 7 H). Here we
demonstrate that it is feasible to induce HO-1 expression in
calvarias co-cultured with prostate tumor cells, probably as a
defense mechanism to maintain the organ homeostasis.
Growth of PC3HO-1 tumors in bone
Because PC3 cells produce an osteolytic reaction, we next
investigated the effect of HO-1 induction in PCa cells growing
in the bone. We injected HO-1 stable transfected PC3 cells
(PC3HO-1) or their controls (PC3βgal) in the femur of SCID
Figure 2.  Co-culture with HO-1-induced PC3 cells did not affect osteoblasts differentiation.  Experiments were done in PMOs
grown alone (PMO), co-cultured with PC3 (PMO PC3) or with PC3 pre-treated with hemin (PMO PC3 Hem). Total RNA was
extracted and Runx-2 (A), ALP (B), collagen type I (C), collagen type II (D) and OCN (E) mRNA levels were analyzed by RT-qPCR.
Data were normalized to β-actin and were expressed as fold induction respect to PMOs. One representative from at least three
independent experiments is shown (Significant difference, * P<0.05; ** P<0.01).
doi: 10.1371/journal.pone.0080315.g002
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mice. After 2 weeks, PC3HO-1 and PC3βgal derived-tumors
were detected by X-rays and bone remodeling was observed.
The bones injected with PC3HO-1 presented thickness and
loss of the normal structure. Robust osteolytic reaction was
detected in the PC3HO-1 bearing bones, with decalcified sites
(Figure 8). None of the contralateral legs of any injected
mouse showed evidence of bone lesions (Figure 8, X-rays).
These findings were confirmed by histologic analyses of the
samples, demonstrating the osteoblastic reaction by the
presence of immature bone, mainly in PC3HO-1 metastasis
(Figure 8). Furthermore, in tumors of both groups, mitotic
figures of normal and abnormal features were evident.
The forced expression of HO-1 in PC3 cells growing in the
femur of SCID mice was confirmed by immunohistochemistry
(Figure 8 E&F). Notably, HO-1 nuclear localization was
observed in PC3HO-1 metastasis giving support to our
previous reports revealing HO-1 expression in the nucleus of
human primary prostate carcinomas [9], in PCa cell lines and in
PC3HO-1 s.c. xenografts [10,12].
Discussion
In this manuscript we have explored the effect of the
induction of HO-1 in the interaction between PC3 cells and
bone, the main site of this disease progression. Our studies
indicate that hemin pre-treatment of PC3 cells restored
osteoblasts proliferation probably by a mechanism mediated by
FoxO activation. Furthermore, the inoculation of PC3HO-1 cells
in the femur of mice produced strong bone remodeling.
Figure 3.  Co-culture with HO-1-induced PC3 cells decreased the expression of osteoclast-modulating factors in
osteoblasts.  Experiments were done in PMOs grown alone (PMO), co-cultured with PC3 (PMO PC3) or with PC3 pre-treated with
hemin (PMO PC3 Hem). Total RNA was extracted and RANKL (A), OPG (B), CSF-1 (C), OPN (D), CCL2 (E) and IL-6 (F) mRNA
levels were analyzed by RT-qPCR. Data were normalized to β-actin and were expressed as fold induction respect to PMOs. One
representative from at least three independent experiments is shown (Significant difference, * P<0.05; ** P<0.01; *** P<0.001).
doi: 10.1371/journal.pone.0080315.g003
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The pathogenesis of PCa reflects hereditary and
environmental components. The cytokines, chemokines and
MMPs are a proinflammatory network that contributes directly
to the malignant progression and correlates with invasion,
angiogenesis and metastasis [25].
We have previously suggested that HO-1 acts as a rheostat
controlling prostate tumorigenesis. We demonstrated that HO-1
up-regulation induced its nuclear localization and inhibited cells
proliferation, migration and invasion. Moreover, it impaired
tumor growth in vivo and down-regulated the expression of
target genes associated with inflammation and angiogenesis
[10,11]. Furthermore, we recently documented that HO-1
antitumorigenic properties are partially due to the impairment of
the androgen receptor signaling mediated by the blockade of
the STAT3 axis [12]. Additionally, we demonstrated for the first
time that HO-1 associates to promoters, such as uPA, PSA,
MMP9, suggesting a novel function for this protein in the
nucleus beyond its classic cytoplasmic enzymatic role in heme
degradation [12].
In the bone microenvironment HO-1 mRNA has been shown
to be present in osteoblast, osteocytes and osteoclasts [26].
However, the protein levels are very low in normal osteoblasts
and osteoclasts.
Several factors released by PCa cells participate in the
pathophysiology of prostate cancer progression in bone [27].
The prostate cancer cell line MDA PCa 2b, that produces
mainly osteoblastic lesions, induced osteoblasts proliferation
and differentiation and new bone formation in vivo while PC3
cells that produces an osteolytic reaction, inhibited osteoblasts
proliferation in vitro. Furthermore, the WNT canonical pathway
modulated the osteoblasts function and DKK1 was identified to
be involved in the balance between bone formation and
resorption determining the lesion phenotype [13,18]. In this
paper we investigated the impact of the pharmacological
induction of HO-1 in PC3 cells on bone response.
Figure 4.  The expression of genes implicated in osteoclasts modulation is not altered in PC3 cells by co-culturing with
osteoblasts.  PC3 cells were pre-treated with hemin (80 μM, 24 h, black columns) or not (control, white columns) and co-cultured or
not with PMOs. Total RNA was extracted and PTHrP (A), uPA (B) and TGF-β1 (C) mRNA levels were analyzed by RT-qPCR. Data
were normalized to β-actin and were expressed as fold induction respect to PC3. Gelatin zymography was done to assess MMP9
activity on conditioned media from PC3 grown alone (PC3), pre-treated with hemin (PC3 Hem) and from PMOs grown alone (PMO)
and co-cultured with PC3 pre-treated or not with hemin (PMO PC3 Hem and PMO PC3, respectively). Clear bands were quantified
using ImageJ 1.37.v software (NIH) and normalized to total protein. One representative from at least three independent experiments
is shown (NS: No significant difference; R.V.: relative values).
doi: 10.1371/journal.pone.0080315.g004
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The imbalance in the oxidative status seems to participate in
the pathogenesis of PCa and was suggested that the advanced
disease is associated with a state of high oxidative stress [28].
Our results provide evidence that hemin treated-PC3 cells
challenges the osteoblasts oxidative balance in vitro, reflected
by the increased levels of the antioxidants enzymes. The
presence of PC3 cells in the co-culture unveils a link between
oxidative stress and the bone reaction. Their presence triggers
the FoxO signaling cascade, partly responsible of the
restoration of the proliferation of osteoblasts. It was proposed
that the osteoblasts oxidative status may contribute to the
establishment of the oxidative profile in PCa patients and the
oxidative profile appears to be modified by bone metastasis,
treatment and Gleason score [28]. Moreover, aggressiveness
of PCa was demonstrated to be associated with a high
oxidative stress status. In our in vivo experiments, the oxidative
balance leads to bone remodeling and HO-1 induction in
reactive osteoblasts. However, more studies are necessary to
confirm the exact connection of the role of oxidative stress,
HO-1 response and PCa-derived bone metastasis.
In normal bone, there is a strict equilibrium between bone
resorption and formation, including the maintenance of the
bone metabolism and its structural integrity. Under
inflammatory conditions the bone balance is interrupted, which
depends on two critical factors RANKL and OPG [29]. In our
study the presence of PC3 cells produced an increased in
RANKL and a decreased in OPG, resulting in a net increase in
the RANKL/OPG ratio and therefore in the bone resorption. It is
clear that factors derived from PC3 cells impact bone balance
[13]. In this work, we also observed that hemin pre-treatment of
tumor cells altered PC3 milieu and in turn osteoblasts
recovered their proliferative capacity, probably by re-gaining
their homeostasis. The co-culture of PMOs with hemin-
pretreated PC3 cells diminished the expression of CCL2, OPN
and CSF-1, genes involved in osteoclastogenesis, migration,
maturation and adhesion of osteoclasts. Furthermore, Runx-2
Figure 5.  Co-culture with HO-1-induced PC3 cells induced oxidative stress markers in osteoblasts.  Experiments were done
in PMOs grown alone (PMO), co-cultured with PC3 (PMO PC3) or with PC3 pre-treated with hemin (PMO PC3 Hem). Total RNA
was extracted and MnSOD (A) and catalase (B) mRNA levels were analyzed by RT-qPCR. Data were normalized to β-actin and
were expressed as fold induction respect to PMOs. HO-1 protein levels (C) were determined by Western blot analysis. The numbers
under the bands indicates the quantitation normalized to β-actin and PMOs alone. ROS levels (D) were determined in PMOs
incubated with CM2-DCFHDA and measured by flow citometry in the FITC channel (Significant difference, * P<0.05; ** P<0.01).
doi: 10.1371/journal.pone.0080315.g005
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Figure 6.  Co-culture with HO-1-induced PC3 cells did not change β-catenin localization but activated FoxO signaling in
osteoblasts.  Upper panel. Experiments were done in C2C12 grown alone (C2C12), co-cultured with PC3 (C2C12 PC3) or with
PC3 pre-treated with hemin (C2C12 PC3 Hem). A: The cells were transfected with a FoxO reporter gene construct (FoxO-luc). H2O2
was used as a positive control. B: The cells were transfected with a TCF reporter gene construct (TOP-flash) or its negative control
(FOP-flash). LiCl was a positive control. Six hours after transfection, the C2C12 cells were co-cultured and 24h after co-culturing the
C2C12 cells were lysed and luciferase activity assay was done. Data were normalized to protein values. One representative from at
least three independent experiments is shown (Significant difference, * P<0.05). Lower panel. C: β-catenin cellular distribution was
visualized by immunofluorescence staining (red) of PMOs grown alone (PMO), co-cultured with PC3 (PMO PC3) or with PC3 pre-
treated with hemin (PMO PC3 Hem). The nucleus was labelled using Hoescht stain (green). The Merge represents the overlapping
images. A representative image for each group is shown. Scale bar: 30 μm.
doi: 10.1371/journal.pone.0080315.g006
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transcripts were significantly induced in PMOs by co-culturing
with hemin-pretreated cells. Pratap et al [30] proposed Runx-2
as a bone microenvironment sensor that controls osteoblasts
proliferation in response to growth signals. Thus, considering
the regulatory role exerted by osteoblasts on osteoclasts, our
data suggest that the co-culture of PMOs with HO-1-induced
PC3 cells affected the dialogue between osteoblasts and
osteoclasts.
Inflammation is related to bone loss and inflammatory
disorders are precipitators of enhanced bone resorption
producing osteoporosis [31]. The onset of osteoclastogenesis
and the consequent bone loss are precipitated by typical
inflammatory molecules [32]. It was demonstrated that HO-1
influenced osteoclastogenesis in vitro and in vivo, that HO-1
activity negatively regulated inflammatory bone destruction and
that HO-1 up-regulation impaired osteoclasts differentiation
[26,33]. Vanella et al [34] and Bargaballo et al [35] reported
that bone marrow mesenquimal stem cells displayed
osteoblasts linage differentiation under HO-1 induction. This
positive control exerted by HO-1 on osteoblasts differentiation
was suggested to be associated to oxidative stress and to the
induction of OPG and OCN [34]. Moreover, in osteoarthritis
HO-1 was proposed to be an osteoblasts cytoprotective protein
[36]. Lin et al [37], using primary cultured osteoblasts,
demonstrated that HO-1 induction inhibited the maturation of
osteoblasts including mineralized bone formation.
The results in the present study suggest that increased HO-1
expression in osteoblasts may be an adaptive mechanism to
maintain the homeostasis of the bone tissue in response to the
aggressiveness produced by the inflammatory milieu induced
by PCa cells.
Figure 7.  Co-culture with HO-1-induced PC3 cells increased HO-1 expression in bone explants.  Upper panel. H&E staining
of representative neonatal mouse calvariae cultured in vitro in the absence (A) or presence of PC3 cells control (B) or PC3 cells
pre-treated with hemin (C). Insulin was used as a positive control of bone formation (D). Lower panel. Immunohistochemical
staining of HO-1 of representative neonatal mouse calvariae cultured in vitro in the absence (E) or presence of PC3 cells control (F)
or PC3 cells pre-treated with hemin (G). The arrows indicate the positive immunostaining in active osteoblasts. Magnification, x 250.
The bands indicate the percentage of HO-1 positive osteoblasts respect to total active osteoblasts (H) (Significant difference, *
P<0.05; ** P<0.01).
doi: 10.1371/journal.pone.0080315.g007
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Figure 8.  Histological analysis of intra-osseous
metastasis.  PC3HO-1 cells and PC3βgal were injected into
distal head of the right femur of SCID mice. Upper panel, X-ray
imaging of mouse legs after intrabone injection of PC3HO-1 or
PC3βgal cells. Red arrow, injected limb. Lower panel,
longitudinal section of mouse femur stained with H&E (A&B,
magnification x 100; C, magnification x 400; D, magnification x
250). The red arrow heads indicate cartilage; black circle,
tumor; black arrows, immature bone and black head arrows
mature bone. Immunohistochemistry of HO-1 (E&F,
magnification x 400) with scattered cells positive in cytoplasm
(black arrows).
doi: 10.1371/journal.pone.0080315.g008
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Supporting Information
Figure S1.  HO-1 expression in PC3 cells co-cultured or not
with PMOs. PC3 cells were pre-treated with hemin (80 μM, 24
h, black columns) or not (control, white columns) and co-
cultured or not with PMOs. HO-1 mRNA levels were
determined by RT-qPCR (A) and protein levels by Western
blot. Data were normalized to β-actin and were expressed as
fold induction respect to PC3. One representative from at least
three independent experiments is shown (Significant
difference, * P<0.05).
(TIF)
Figure S2.  Von Kossa. To determine calcified matrix
deposition, von Kossa staining was applied to PMOs. After the
co-culture, the PMOs grown alone (PMO), co-cultured with
PC3 (PMO PC3) or with PC3 pre-treated with hemin (PMO
PC3 Hem) were cultured for 21 days in differentiation medium
and it was changed every 2 days.
(TIF)
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